The 2 Chain Restaurants Texas Roadhouse Owns
Bubba's 33 is a sports-themed family restaurant that serves typical American fare such as hamburgers, pizza, and wings. The standard sports bar-type atmosphere and food are a far cry from Texas Roadhouse's Western theme. Jaggers serves similar food to Bubba's, though it's focused more on burgers, chicken, and salads, and has more of a fast-casual setup focused on speed and efficiency. Yet, for all those differences, there's some key shared details: both Jaggers and Bubba's 33 were founded by Kent Taylor, the same man who created Texas Roadhouse.
All three restaurant chains have enjoyed success thus far, with Texas Roadhouse alone featuring nearly 800 locations in 49 U.S. states and 10 nations. As of writing, Bubba's 33 has 49 total locations in 15 states, and Jaggers boasts 20 locations across seven states and at least one restaurant in South Korea. It's no surprise that Texas Roadhouse is the biggest of the three, given that it's the company's main focus and has been in business since 1993, decades before the 2013 debut of Bubba's 33 and Jaggers' entrance onto the restaurant scene in 2014.
Read more: The Fast Food Chains That Use Fresh Never Frozen Burgers
Texas Roadhouse Is Expanding Its Other Brands
Texas Roadhouse executives have been very pleased with both Bubba's 31 and Jaggers' success and are looking to further expand both restaurants. In Q1 of 2024, Bubba's pulled in average weekly sales of $120,000. As CEO Jerry Morgan told Nation's Restaurant News that year, it has "a growing pipeline for the coming years." Between Texas Roadhouse and Bubba's, 30 new locations are scheduled to open in 2025. While it's unclear exactly how many of these locations will be Bubba's 31-branded, the future looks promising for the restaurant nonetheless.
Similarly, Jaggers is expected to open additional locations in 2025, including three franchise partners and additional international locations. Jaggers' growth has been slower than Bubba's or Texas Roadhouse due to its focus on fast dining and the company's efforts to establish itself in a relatively new-to-them industry.
What all this expansion means for Texas Roadhouse itself is unclear. Still, company leadership has expressed confidence, while the current and projected numbers are hard to ignore. Given that Texas Roadhouse recently dethroned Olive Garden, it surely seems wise to continue the support of the company's biggest money-maker while also working on the two subsidiary brands.
Read the original article on Foodie.
Solve the daily Crossword
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Thermo Fisher beats quarterly estimates on resilient demand for its tools and services
(Reuters) -Thermo Fisher on Wednesday beat Wall Street estimates for second-quarter profit and revenue, helped by steady demand for its products and services used for developing therapies. Shares of the medical equipment maker were up 2.5% in premarket trading. The company joins peers such as Danaher in beating quarterly profit estimates, citing strong demand from the industry for tools and services used to make vaccines and therapies. Danaher said on Tuesday it is seeing a robust number of clinical trials and therapies under development, with steady demand from its pharmaceutical clients. On an adjusted basis, Thermo Fisher reported a profit of $5.36 per share for the quarter ended June 28, beating analysts' estimate of $5.22 per share, as per data compiled by LSEG. The company said its business strategy called "practical process improvement" is helping adjust its supply chains in the tariff environment and to actively manage its cost base. Last week, the company said it will buy French drugmaker Sanofi's New Jersey manufacturing site, "to meet growing demand from pharma and biotech customers." The Waltham Massachusetts-based company's quarterly revenue rose 3% to $10.85 billion, compared to analyst estimates of $10.68 billion. Sales at its laboratory products segment, which makes up more than half of Thermo Fisher's total sales came in at $6 billion, above estimates of $5.79 billion. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
16 minutes ago
- Yahoo
Highly shorted Krispy Kreme, GoPro jump as meme stock rally continues
(Reuters) -Shares of some highly-shorted companies, including Krispy Kreme and GoPro, jumped in premarket trading on Wednesday, aided by their names trending on social media forums a day after retail traders piled into department store company Kohl's. Doughnut chain Krispy Kreme jumped 16.1%, building on a near 27% surge on Tuesday. About 14% of Krispy Kreme's outstanding shares available for trading are shorted, according to data compiled by LSEG. Camera maker GoPro also surged about 47% to $2.01. Short interest on the stock was last at 7.7%. Another highly shorted stock - with short interest at 36.7% - was plant-based meat company Beyond Meat, whose shares jumped 10.4% on Wednesday. The growing interest in heavily shorted stocks comes after Kohl's surged 37.6% higher in volatile trading on Tuesday on the back of high retail interest. Mom-and-pop traders bought $9.64 million of its shares that day, the most by this category of investors in about three years, according to data from Vanda Research. Kohl's was flat in premarket trading on Wednesday but is the third most trending ticker on Stocktwits, a retail investor-focused social media platform. Among other highly shorted names, online gifts retailer rose 8.1%. Opendoor Technologies, which has rocketed 440% so far this month, was down 2.6% on Wednesday.

Yahoo
16 minutes ago
- Yahoo
Thermo Fisher shares climb as Q2 top and bottom line exceed estimates
-- Thermo Fisher Scientific Inc (NYSE:TMO) reported second-quarter earnings that topped expectations, with revenue also coming in ahead of forecasts. The company reported adjusted EPS of $5.36, beating the analyst estimate of $5.23. Revenue rose 3% from a year earlier to $10.85 billion, above the $10.68 billion consensus. Shares in the medical equipment maker were up 2.3% in premarket trading Wednesday as of 06:06 ET. 'Our exceptional team continues to execute at a high level, enabling customer success while navigating the macroenvironment," said Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific. Adjusted operating income reached $2.38 billion, slightly up from $2.35 billion in the same period last year. Adjusted operating margin slipped to 21.9% from 22.3% a year ago. Related articles Thermo Fisher shares climb as Q2 top and bottom line exceed estimates These Under-the-Radar Stocks Offer Better Risk-Reward Ratio Than Nvidia If Powell goes, does Fed trust go with him?